Co-Authors
This is a "connection" page, showing publications co-authored by JANICE BLALOCK and GEORGE KYPRIOTAKIS.
Connection Strength
0.800
-
Examining the Association between Abstinence from Smoking and Healthcare Costs among Patients with Cancer. Cancer Prev Res (Phila). 2024 May 02; 17(5):217-225.
Score: 0.243
-
Association of a Comprehensive Smoking Cessation Program With Smoking Abstinence Among Patients With Cancer. JAMA Netw Open. 2019 09 04; 2(9):e1912251.
Score: 0.176
-
Smoking Cessation After Initial Treatment Failure With Varenicline or Nicotine Replacement: A Randomized Clinical Trial. JAMA. 2024 05 28; 331(20):1722-1731.
Score: 0.061
-
Comparing the Fagerstr?m Test and Heaviness of Smoking Index in Predicting Smoking Abstinence in Cancer Patients. Nicotine Tob Res. 2024 May 24.
Score: 0.061
-
Brief report: Characterization of electronic cigarette use among patients of a comprehensive cancer center. Am J Addict. 2024 05; 33(3):339-342.
Score: 0.058
-
The Effects of Scheduled Smoking Reduction and Precessation Nicotine Replacement Therapy on Smoking Cessation: Randomized Controlled Trial With Compliance. JMIR Form Res. 2023 Jun 20; 7:e39487.
Score: 0.057
-
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial. Depress Anxiety. 2022 05; 39(5):429-440.
Score: 0.053
-
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. Am J Addict. 2022 05; 31(3):236-241.
Score: 0.052
-
Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis. J Clin Psychopharmacol. 2018 Feb; 38(1):34-41.
Score: 0.039